In a Golden Age of Cancer Care, PBMs Are Holding Us Back
Patt is an oncologist specializing in breast cancer. *Patient name has been changed We're living in a remarkable time for...
Patt is an oncologist specializing in breast cancer. *Patient name has been changed We're living in a remarkable time for...
Continuation patents on FDA-approved drugs skyrocketed by 200% from 2000 to 2015, likely putting off generic competition, researchers found. Over...
Readers of this blog know that no one has been more critical of Obamacare's flaws––particularly over the impact the program...
Lawmakers clashed over the safety of gender-affirming care in minors on Thursday, during a hearing of the House Judiciary Subcommittee...
President Trump said over the weekend, "If I'm victorious on November 3rd, I plan to forgive these and make permanent...
While expressing reservations, an advisory committee to the FDA backed clinical development plans for dostarlimab (Jemperli) in untreated locally advanced...
Since it's been a long time since we've had it, I thought you would appreciate seeing this: Source link
(MedPage Today) -- Low-income blacks under 50 also had a high risk of heart problems SOURCE: MedPage Today Public Health...
Drs. David Himmelstein and Steffie Woolhander are the Bernie Sanders of health policy. For decades, they have advocated that the...
(MedPage Today) -- Delaware once first in the nation for cancer mortality is now 15th SOURCE: MedPage Today Public Health...
(MedPage Today) -- Physicians limiting "low-value" tests find patients need extra explanation SOURCE: MedPage Today Public Health & Policy -...